| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,565 |
4,099 |
$210K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,919 |
1,843 |
$126K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,483 |
1,403 |
$105K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,551 |
1,478 |
$102K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,882 |
2,633 |
$78K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,946 |
3,712 |
$54K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,222 |
2,073 |
$45K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
520 |
484 |
$30K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
353 |
320 |
$24K |
| 92551 |
|
2,590 |
2,461 |
$19K |
| 92567 |
|
1,038 |
963 |
$11K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
711 |
679 |
$10K |
| 83655 |
|
794 |
660 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
518 |
221 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
497 |
406 |
$5K |
| 99173 |
|
2,612 |
2,470 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
52 |
49 |
$2K |
| 90474 |
|
93 |
91 |
$830.83 |
| 90621 |
|
491 |
429 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
700 |
648 |
$0.00 |
| 90633 |
|
613 |
586 |
$0.00 |
| 90649 |
|
432 |
410 |
$0.00 |
| 90707 |
|
160 |
142 |
$0.00 |
| 90713 |
|
41 |
40 |
$0.00 |
| 90700 |
|
246 |
227 |
$0.00 |
| 90734 |
|
306 |
296 |
$0.00 |
| 90715 |
|
41 |
37 |
$0.00 |
| 90670 |
|
610 |
580 |
$0.00 |
| 90648 |
|
320 |
305 |
$0.00 |
| 90685 |
|
80 |
74 |
$0.00 |
| 90686 |
|
1,013 |
970 |
$0.00 |
| 97802 |
|
5,027 |
4,453 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
702 |
648 |
$0.00 |
| 90680 |
|
113 |
91 |
$0.00 |
| 90716 |
|
162 |
144 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
13 |
13 |
$0.00 |
| 90723 |
|
116 |
115 |
$0.00 |